Murai-Kushiya M, Okada S, Kimura T, Hasegawa R
National Institute of Hygienic Sciences, Osaka Branch, Japan.
J Pharm Pharmacol. 1993 Mar;45(3):225-8. doi: 10.1111/j.2042-7158.1993.tb05539.x.
The stereoselectivity of binding of four beta-blockers, pindolol, propranolol, oxprenolol and acebutolol, to purified rat alpha 1-acid glycoprotein (AAG) was examined using equilibrium dialysis. Pindolol and propranolol were bound stereoselectively to AAG, whereas binding of oxprenolol was non-stereospecific. Neither of the enantiomers of acebutolol bound to either AAG or any other plasma protein. The affinity of (+)-pindolol was 25 times that of (-)-pindolol, as determined in a single enantiomer experiment. Both enantiomers of propranolol demonstrated two classes of binding sites in AAG, the total binding for the high affinity site for (+)-propranolol being double that of (-)-propranolol, which could explain the higher binding of the (+)-enantiomer in racemate experiments. These results further showed that stereoselective binding to a rat AAG is not a property common to all beta-blockers.
使用平衡透析法研究了四种β受体阻滞剂(吲哚洛尔、普萘洛尔、氧烯洛尔和醋丁洛尔)与纯化的大鼠α1-酸性糖蛋白(AAG)结合的立体选择性。吲哚洛尔和普萘洛尔与AAG的结合具有立体选择性,而氧烯洛尔的结合是非立体特异性的。醋丁洛尔的对映体均不与AAG或任何其他血浆蛋白结合。在单一对映体实验中测定,(+)-吲哚洛尔的亲和力是(-)-吲哚洛尔的25倍。普萘洛尔的两种对映体在AAG中均表现出两类结合位点,(+)-普萘洛尔高亲和力位点的总结合量是(-)-普萘洛尔的两倍,这可以解释在消旋体实验中(+)-对映体的结合率更高。这些结果进一步表明,与大鼠AAG的立体选择性结合并非所有β受体阻滞剂共有的特性。